100% Chitosan Haemostatic Dressing
Axiostat is a sterile, non-absorbable haemostatic dressing intended to control bleeding within minutes of application by providing an active mechanical barrier to the wound site.
Haemodialysis patients often experience a lot of additional discomfort due to the time it can take for a clot to form on the access point, post dialysis. The Axiostat Hemodialysis variant is effective in speeding up the natural clotting process, especially on patients who are on multiple anticoagulants. It is recommended for Haemodialysis, CVC, and any vascular access procedures including arterial/central line removal.
- Sterile, ready to use
- Hypoallergenic, no known side-effects
- Effective in patients on blood thinners
Based on patented, clinically validated a.c.t (Axio clotting technology)
intended use / indication
- Stop bleeding after removal of needle in hemodialysis procedures
- Works effectively on patients who are on multiple anticoagulants
- Provides anti-microbial barrier and reduction in catheter related infections
- Easily removed by using saline or water and helps in preservation of fistula
|Composition||Chitosan - 100%|
|Indication||Stops severe bleeding|
|Mechanism||Mucoadhesion due to charge|
|Material||Positively charged, reacts actively|
|Type||Sponge, natural polymer|
|Sterility||Sterilized using Gama irradiation|
|Shelf Life||3 Years|
|Removal||Irrigate with saline|
|Side Effects||No side effects|
how to use axiostat
HOW IT WORKS?
- Studying Hemostatic Effect of Axiostat® Dressing on Radial Access After Percutaneous Procedure (AHD). ClinicalTrials.gov Identifier: NCT02837744.
- Chitosan enhances platelet adhesion and aggregation. Chou TC. et al. Biochemical and Biophysical Research Communications; 2003, 302(3):480-3.
- Effect of chitosan molecular weight and deacetylation degree on hemostasis. Yang J. et al. Journal of Biomedical Material Research: Part B, Applied Biomaterials; 2008, 84(1):131-7.
- Percutaneous microcrystalline chitosan application for sealing arterial puncture sites. Hoekstra A, Struszczyk H, Kivekäs O. Biomaterials; 1998, 19(16):1467-71.
- A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Achneck HE. et al., Annals of Surgery. 2010, 251(2):217-28.